GlycoMimetics, Inc. (GLYC)

GlycoMimetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.72	41.79	47.87	90.25	137.04
Cash & Short-Term Investments	10.72	41.79	47.87	90.25	137.04
Cash Growth	-74.35%	-12.70%	-46.96%	-34.14%	-13.38%
Other Receivables	0.14	0.18	0.14	0	0
Receivables	0.14	0.18	0.14	0	0
Prepaid Expenses	0.23	1.82	2.7	0.53	1.24
Total Current Assets	11.09	43.79	50.71	90.79	138.27
Property, Plant & Equipment	-	0.77	0.75	1.95	2.95
Other Long-Term Assets	-	0.76	0.34	1.61	1.61
Total Assets	11.09	45.32	51.81	94.35	142.83
Accounts Payable	0.33	0.87	0.97	2.11	2.09
Accrued Expenses	5.38	5.23	6.99	8.72	9.44
Current Portion of Leases	0.07	0.74	0.92	1	0.9
Total Current Liabilities	5.78	6.84	8.88	11.82	12.43
Long-Term Leases	-	0.07	-	0.92	1.92
Other Long-Term Liabilities	-	-	-	-	0.26
Total Liabilities	5.78	6.9	8.88	12.74	14.61
Common Stock	0.06	0.06	0.05	0.05	0.05
Additional Paid-In Capital	499.61	494.84	462.46	454.45	437.64
Retained Earnings	-494.36	-456.49	-419.59	-372.9	-309.47
Shareholders' Equity	5.31	38.41	42.93	81.6	128.22
Total Liabilities & Equity	11.09	45.32	51.81	94.35	142.83
Total Debt	0.07	0.81	0.92	1.92	2.82
Net Cash (Debt)	10.65	40.98	46.95	88.33	134.22
Net Cash Growth	-74.01%	-12.71%	-46.85%	-34.19%	-13.17%
Net Cash Per Share	0.17	0.65	0.89	1.72	2.94
Filing Date Shares Outstanding	64.51	64.45	64.25	52.31	51.49
Total Common Shares Outstanding	64.48	64.39	54.38	52.31	49.02
Working Capital	5.31	36.96	41.83	78.96	125.84
Book Value Per Share	0.08	0.60	0.79	1.56	2.62
Tangible Book Value	5.31	38.41	42.93	81.6	128.22
Tangible Book Value Per Share	0.08	0.60	0.79	1.56	2.62
Machinery	-	-	-	2.08	2.14
Leasehold Improvements	-	-	-	0.62	0.62

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q